Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: A matter of trust

At this point I don't have any trust in PTSC's ability in growing the business through M&A and R&D. Been there, seen the attempts at it, and witnessed the failures.

I'm for strictly turning the cash over to the shareholders (after expenses) via dividends.

Dividend stocks do very well at this time. A company issuing a steady flow of dividends given on a regular basis will certainly cause share price appreciation and the BOD has nothing more to do than keep a watchful eye on DL (which is a tough job in itself) and distribute the cash. I don't mind seeing the directors making excess cash if I'm also making excess cash along with them.

GL

Share
New Message
Please login to post a reply